Diabetes mellitus

Endocrinology

Nastech Pharmaceutical Company Inc. Enters Agreements with Research Partners for Nasal Delivery of Diabetes and Alzheimer Disease Treatments

Nastech Pharmaceutical Company Inc. has announced the signing of separate agreements with two undisclosed research partners to evaluate the development of proprietary formulations for the nasal delivery of compounds useful for the treatment of type 2 diabetes and Alzheimer disease. The company will utilize its proprietary Tight Junction technology to